Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
Lipids Health Dis. 2011 Oct 21;10:186. doi: 10.1186/1476-511X-10-186.
The plasma lipoprotein response of F1B Golden-Syrian hamsters fed diets high in very long chain (VLC) n-3 polyunsaturated fatty acids (PUFA) is paradoxical to that observed in humans. This anomaly is attributed, in part, to low lipoprotein lipase activity and is dependent on cholesterol status. To further elucidate the mechanism(s) for these responses, hamsters were fed diets containing supplemental fish oil (VLC n-3 PUFA) or safflower oil (n-6 PUFA) (both 10% [w/w]) and either cholesterol-supplemented (0.1% cholesterol [w/w]) or cholesterol-depleted (0.01% cholesterol [w/w] and 10 days prior to killing fed 0.15% lovastatin+2% cholestyramine [w/w]).
Cholesterol-supplemented hamsters fed fish oil, relative to safflower oil, had higher non-high density lipoprotein (HDL) cholesterol and triglyceride concentrations (P < 0.001) which were associated with lower hepatic low density lipoprotein (LDL) receptor, sterol regulatory element binding protein (SREBP)-1c and acyl-CoA: cholesterol acyl transferase-2 (ACAT) mRNA and protein (p < 0.05), and higher hepatic apolipoprotein (apo) B-100 and apo E protein levels. In contrast, cholesterol-depleted hamsters fed fish oil, relative to safflower oil, had lower non-HDL cholesterol and triglyceride concentrations (P < 0.001) which were associated with lower hepatic SREBP-1c (p < 0.05) but not apo B-100, apo E or ACAT-2 mRNA or protein levels. Independent of cholesterol status, fish oil fed hamsters had lower HDL cholesterol concentrations (p < 0.001), which were associated with lower hepatic apoA-I protein levels (p < 0.05).
These data suggest disturbing cholesterol homeostasis in F1B hamsters alters their response to dietary fatty acids, which is reflected in altered plasma lipoprotein patterns and regulation of genes associated with their metabolism.
F1B 金黄叙利亚仓鼠食用富含超长链(VLC)n-3 多不饱和脂肪酸(PUFA)的饮食后,其血浆脂蛋白的反应与人类观察到的反应相反。这种异常部分归因于脂蛋白脂肪酶活性低,并取决于胆固醇状态。为了进一步阐明这些反应的机制,给仓鼠喂食含有补充鱼油(VLC n-3 PUFA)或红花油(n-6 PUFA)(均为 10%[w/w])的饮食,并补充胆固醇(0.1%胆固醇[w/w])或去胆固醇(0.01%胆固醇[w/w]和在杀死前 10 天喂食 0.15% lovastatin+2% cholestyramine [w/w])。
与红花油相比,补充胆固醇的食用鱼油的仓鼠的非高密度脂蛋白(HDL)胆固醇和甘油三酯浓度更高(P <0.001),这与肝低密度脂蛋白(LDL)受体、固醇调节元件结合蛋白(SREBP)-1c 和酰基辅酶 A:胆固醇酰基转移酶-2(ACAT)mRNA 和蛋白(p <0.05)降低以及肝载脂蛋白(apo)B-100 和 apoE 蛋白水平升高有关。相比之下,与红花油相比,去胆固醇的食用鱼油的仓鼠的非-HDL 胆固醇和甘油三酯浓度更低(P <0.001),这与肝 SREBP-1c 降低有关(p <0.05),但与 apoB-100、apoE 或 ACAT-2 mRNA 或蛋白水平无关。与胆固醇状态无关,食用鱼油的仓鼠的 HDL 胆固醇浓度较低(P <0.001),这与肝载脂蛋白 A-I 蛋白水平降低有关(p <0.05)。
这些数据表明,F1B 仓鼠的胆固醇稳态紊乱改变了它们对膳食脂肪酸的反应,这反映在改变的血浆脂蛋白模式和与它们的代谢相关的基因的调节上。